Leading Beauty Brands Harness Tech Innovations For Personalized Solutions; CES News In Brief

P&G, J&J/Neutrogena and L’Oreal/La Roche-Posay are among firms exhibiting technologies at the Consumer Electronics Showcase in Las Vegas that provide personalized skin benefits.

Touch the future,Interface technology, the future of user experience.

The Opté Precision Skincare System from P&G Ventures, the consumer goods giant’s startup studio, consists of a handheld wand that scans for dark spots and makes instant, targeted corrections with a serum that not only provides coverage but long-term benefits as well. Announced Jan. 4 by Procter & Gamble Co. and exhibiting Jan. 8-11 at the Consumer Electronics Showcase in Las Vegas, the innovation relies on blue LED scan lights to detect contrasts in skin melanin, including discoloration currently invisible to the naked eye; a digital camera that captures 200 skin images per second; a minicomputer algorithm to determine the exact size, shape and intensity of each spot; and a micro jet printer to layer spots with serum in billionth-of-a-liter droplets. According to P&G, the serum includes mineral pigments to cover, lightening agents to improve spots over time and moisturizing ingredients to keep skin hydrated. “Most women only need treatment on approximately 10 percent of their skin. … Opté's proprietary technology allows it to treat only the small areas that need correction without covering the skin that doesn't, resulting in a natural, flawless look that makeup and professional treatments are unable to achieve,” P&G says. A demo of the product at work can be viewed at OpteSkin.com, where visitors also can sign up “to be one of the first consumers in the world to experience Opté.”

Neutrogena MaskiD

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Strategy

Asking For More: Supplement MPL Authority For FDA, Agency Results For Congress, Industry

Following Energy and Commerce Health Subcommittee hearing about FDA’s human food and tobacco programs on 10 September, gap between what the trade groups, committee leadership and the FDA each want more of doesn’t appear to be shrinking.

HI-Beauty (Free-2): How the Future of Medicine Will Revolve Around Our Gut

 
• By 

The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.

Beauty Brands Not On TikTok Shop ‘Really Missing Out’ – KO-Pack

 

At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”

Lauder’s Outgoing CFO Breaks Down Global Prestige Beauty, Firm’s Transition Moment

 

Global beauty giant is working to adapt its approach to the prestige market to meet escalating competition, increased points of sale, and more knowledgeable consumers with new shopping habits, CFO Tracey Travis said at the Barclays Global Consumer Staples Conference.

More from Business

HI-Beauty (Free-2): How the Future of Medicine Will Revolve Around Our Gut

 
• By 

The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.

ADHD Medications and Cardiovascular Effects: New Data Revealed. (A Comprehensive Evaluation of Emerging Clinical and Epidemiological Evidence on the Cardiovascular Effects Associated with Commonly Prescribed Medications for Attention Deficit Hyperactivity Disorder)

 
• By 

A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.